Skip to main content
. 2021 Nov 10;11:760382. doi: 10.3389/fonc.2021.760382

Figure 3.

Figure 3

Bispecific CD3xCD123 Antibodies For Dual Targeting of MM Stem Cells Clones and MDSC Cells in High-Risk MDS Patients. BsAB, bispecific antibody; MM, Multiple myeloma; MDSC, Myeloid-derived suppressor cell. See text for a detailed discussion of the rationale of targeting the CD123 and CD38 antigens that are expressed on both MM stem cell clones and MDSCs.